Minoxidil + Red-Light Therapy for Hair Loss in Breast Cancer

This trial tests two methods to address hair loss from chemotherapy in breast cancer patients. One group will use minoxidil, a topical treatment that increases blood flow to hair follicles and promotes hair growth. The other group will use minoxidil combined with a red-light therapy cap, which may further stimulate hair growth by activating skin cells. Researchers aim to determine if the combination of these treatments is more effective than minoxidil alone. The trial seeks breast cancer patients who have lost at least half of their scalp hair after completing chemotherapy. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to potential advancements in hair loss solutions.

The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that you should not have ongoing treatment with an antibody-drug conjugate or immunotherapy.

Research has shown that minoxidil is generally safe for breast cancer patients experiencing hair loss. Studies have found that it does not interfere with cancer treatments and is well-tolerated, with no major side effects reported. The FDA has already approved minoxidil for treating hair loss, which further assures its safety.

For low-level red-light therapy, research indicates it is safe, with only minor side effects. This therapy is also FDA-approved for hair loss and is safe for various skin conditions. It uses light that does not harm DNA.

Researchers are excited about these treatments for hair loss in breast cancer patients because they combine familiar therapies in a novel way. Minoxidil, already well-known for its effectiveness in treating hair loss by promoting blood flow to hair follicles, is used in both treatment groups. The unique aspect is the addition of low-level red-light therapy (LLLT) in the second group, which uses the Revian RED LED-light cap. This approach potentially enhances hair regrowth by stimulating cellular activity and reducing inflammation, offering a dual-action treatment that could be more effective than minoxidil alone.

Research has shown that minoxidil, which participants in this trial may receive, can help treat hair loss. In studies, many people using minoxidil have experienced moderate to significant improvement in hair thickness. Minoxidil boosts blood flow to the scalp and encourages hair follicles to move from a resting phase to an active growth phase.